Graciema Bertoletti

Graciema Bertoletti is a seasoned executive with extensive experience in business development, mergers and acquisitions, and partnerships. Currently serving as the Diretora de Novos Negocios, M&A e Parcerias at OdontoPrev since April 2025, Graciema also contributes as a Board Member at Projeto Arrastão since May 2019. Previously, Graciema held the position of Director at IG4 Operations from May 2023 to April 2025, focusing on private equity operations, and was the Chief Growth Officer at Opy Health from October 2021 to March 2025. Additional roles include a Board Member at SulAmérica and serving as Diretora de Produtos Médicos at Amil from October 2016 to October 2021. Graciema's earlier career features partnerships and director roles at G5 | Evercore, Credit Agricole Corporate and Investment Bank, and Morgan Stanley. Graciema holds an MBA from Harvard Business School and a degree in Economics from Universidade Federal do Rio de Janeiro.